Biochips: Market Research Report

January 2019 | 287 pages | ID: B52FD2F6EB6EN
Global Industry Analysts, Inc

Abstracts

This report analyzes the worldwide markets for Biochips in US$ Million by the following Segments: DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Others. The report further analyzes the market by the following Applications: Research, Diagnostics, and Others.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024.

Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

Company profiles are primarily based on public domain information including company URLs. The report profiles 73 companies including many key and niche players such as -

• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• Cepheid Inc.
• Fluidigm Corporation
• GE Healthcare
• Hoffman-La-Roche Ltd.

Contents

1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

2. INDUSTRY OVERVIEW

Biochips - A Primer
Expanding Application Areas
Outlook
DNA Biochips Lead the Application Front
Protein Biochips – Set for Robust Expansion
Lab-on-a-Chip: Fusion of Nanotechnology & Genetic Engineering
Key Applications of Lab-on-a-Chip Technology
Molecular Biology and Lab-On-A-Chip
Proteomics and Lab-On-A-Chip
Cell Biology and Lab-On-A-Chip
Chemistry and Lab-On-A-Chip

3. GROWTH DRIVERS, MARKET TRENDS, AND CHALLENGES

Biochips Aid in Alleviating Issues Associated with Immunological Studies
Challenges for Widespread Adoption
Biochips with CMOS Technology for Aiding Cheaper Cancer and Other Diagnoses
Development of Protein Microarrays for the Field of Diagnostics – Key Challenges
Reproducibility – the Key Issue
Ease of Use
Cost
Implantable Biochip: The Next Thing in the Wearables Market
Going Mainstream
Drug Discovery Applications to Drive Market
Proteomics and Genomics Drive Demand for Biochips
Growing Preference for DNA/Protein Biochips in Personalized Medicine
Application of Biochips in Drug Discovery – A Strong Growth Driver
Cancer: An Important Driver for the Biochips Market

Table 1. World Cancer Incidence by Geographic Region and Gender (2012): Number of New Cancer Cases Reported (in Thousands) for Asia-Oceania, Europe, North America, Latin America & The Caribbean, and Africa (includes corresponding Graph/Chart)

Table 2. Global Incidence of Common Cancers in Men (2012): Number of New Cases Reported in Thousands for Lung & Bronchus, Prostate, Colorectal, and Liver Cancers (includes corresponding Graph/Chart)

Table 3. Global Incidence of Common Cancers in Women (2012): Number of New Cases Reported in Thousands for Breast, Colorectal, Lung & Bronchus, and Liver Cancers (includes corresponding Graph/Chart)

Increasing Prevalence of Lifestyle Diseases Boost Diagnostic Microarray Market
Diabetes – A Statistical Overview

Table 4. Global Diabetes Mellitus Incidence among Ages 20-79 (2017 & 2045): Prevalence (in Millions) and Percentage Share by Geographic Region (includes corresponding Graph/Chart)

Table 5. Global Diabetes Mellitus Incidence among Ages 20-79 (2017 & 2045): Prevalence (in Millions) for Urban and Rural Populations (includes corresponding Graph/Chart)

Table 6. Global Diabetes Mellitus Prevalence among Ages 20-79 (2017 & 2045): Percentage Share of Population Affected by Geographic Region (includes corresponding Graph/Chart)

Table 7. Global Diabetes Mellitus Prevalence by Gender by Age Group (2017) (includes corresponding Graph/Chart)

Table 8. Top 10 Countries with Highest Number of Adults (Ages 20-79) Diagnosed with Diabetes (in Million) for 2017 & 2045 (includes corresponding Graph/Chart)

Table 9. Global Diabetes Mellitus Related Deaths among Ages 20-79 (2017) (includes corresponding Graph/Chart)

Table 10. Diabetes Mellitus Related Healthcare Expenditure among Ages 20-79 by Region: 2017 & 2045 (in US$ Billion) (includes corresponding Graph/Chart)

Table 11. Diabetes Mellitus Related Healthcare Expenditure among Ages 20-79 for Select Countries: 2017 (in US$ Billion) (includes corresponding Graph/Chart)

Table 12. Average Diabetes Related Healthcare Expenditure for Select Countries: 2017 (in US$) (includes corresponding Graph/Chart)

Government Efforts to Promote Biochip Technology
Integrating Tools with Diagnostic Capabilities with Smartphones – A Futuristic Trend
Microfluidic and Lab-on-a-chip Devices for Pharmacogenomics
Lab-on-a-Chip System for Better Pulmonary Disease Outcome
Industry Challenges
Standardization: A Key Challenge
High Costs Restrain Growth
Precise Protein Detection: A Challenge

4. INNOVATIONS IN THE BIOCHIPS INDUSTRY

Biochip Industry Thrives on Innovation
Multi-Dimensional Printing Technology Enables Development of New Biochip Printing Technique
MIT Develops Neuromorphic Chip Capable of Mimicking Human Brain
Novel Biochip Invented for Use in Discovery of Drugs for Neuronal Condition Treatments
Other Developments in the Recent Past:
Biochip Innovations in Drug Discovery Applications
HuRELflow
MetaChip and Subsequent Versions
Lab-on-a-Chip Devices in Smart Delivery of Drugs
Biochips from AYOXXA: A Giant Leap in Protein Multiplexing
Key Developments in the Past

5. PRODUCT OVERVIEW

Biochips – Complex Blend of Biochemistry and Electronics
Historical Perspective
Promising Biochips Promote Biological Research
Lab-on-a-chip: An Enabled Technology
Utility
Evolution and Segmentation
Differing Perspectives
Classification of Biochips
Need for Biochips
Manufacturing Systems Used in Biochip Manufacture
Working of a Biochip
DNA Transcription & Translation through A Biochip
A Functional Model
Cocktail of Disparate Technically Specialized Applications
Biochips: By-product of Multi-disciplinary Sciences
Nanotechnology
BioMEMS
Microfluidics
Micro Total Analysis System

6. BIOCHIP AND MICROARRAY CONSTRUCTION

Chip Architecture
Essence of a Biochip
Concept of a Microarray
Microarray Modules
High Degree of Automation Spurs Biochips Use
Microfabrication Technology in Biochips made from Polymer and Plastics
Micro-optics in Biochips
Liquid Handling Through Micro-Dispensers
Capillary Electrophoresis and Electrochemical Detectors
Other Technologies
Management of Bio-information
Scanning
Microarray Database Management
Classification of DNA Chips
General Description of Spotted cDNA Microarrays
Spotted DNA Arrays
Spotted cDNA Versus Spotted Oligonucleotide Arrays
Limitations of Conventional cDNA Microarrays
Protein Biochips
General Applications of Protein Biochips:
Challenges in the Design of a Protein Biochip
Limitations of Protein Chip Technology
Concluding Remarks for Protein Biochips

7. APPLICATIONS OF BIOCHIPS

Biochips Hold Huge Potential to Fasten Research and Diagnostics
Biochip Uses
Pharmaceutical Investigation
Medical Diagnostics
Advantages of Biosensor Chip Technology
Forensics
Transplantation Screening
Identity Testing
Water and Environmental Testing
Food Industry

8. COMPETITIVE LANDSCAPE

Industry Structure
Entry of the Biggies Bodes Well for the Industry
Major Participants
Affymetrix: A Pioneer Player
Growing Partnerships between Pharma and Biotech Companies
Outsourcing: A Positive Trend
8.1 Focus on Select Players
Agilent Technologies, Inc. (US)
Bio-Rad Laboratories, Inc. (US)
Cepheid Inc. (US)
Fluidigm Corporation (US)
GE Healthcare (US)
Hoffman-La-Roche Ltd. (Switzerland)
Illumina, Inc. (US)
Ocimum Biosolutions Ltd. (India)
PerkinElmer, Inc. (US)
Takara Bio Inc. (Japan)
Takara Bio USA, Inc. (US)
Thermo Fisher Scientific Inc. (US)
8.2 Recent Industry Activity
AYOXXA Introduces LUNARIS System for Protein Analysis
AYOXXA Living Health Introduces LUNARIS Platform in Asia
Takara Bio USA Acquires WaferGen Bio-Systems
Takara Bio USA Acquires Rubicon Genomics
Danaher Acquires Cepheid
Thermo Fisher Acquires Affymetrix
Veredus Laboratories and AVA Launch VereVet Lab-on-Chip Application
Eurofins Scientific Launches Analytical DNA Chip Technology
Agilent Technologies Introduces Updated SurePrint Microarrays
Agilent Technologies Launches GenetiSure Pre-Screen Microarray
Sengenics Acquires Oxford Gene Technology’s Protein Array Technology

9. GLOBAL MARKET PERSPECTIVE

Table 13. World Recent Past, Current & Future Analysis for Biochips by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 14. World Historic Review for Biochips by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 15. World 14-Year Perspective for Biochips by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)

Analysis by Product Segment

Table 16. World Recent Past, Current & Future Analysis for DNA Biochips by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 17. World Historic Review for DNA Biochips by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 18. World 14-Year Perspective for DNA Biochips by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)

Table 19. World Recent Past, Current & Future Analysis for Protein Biochips by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 20. World Historic Review for Protein Biochips by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 21. World 14-Year Perspective for Protein Biochips by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)

Table 22. World Recent Past, Current & Future Analysis for Lab-on-a-Chip by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 23. World Historic Review for Lab-on-a-Chip by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 24. World 14-Year Perspective for Lab-on-a-Chip by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)

Table 25. World Recent Past, Current & Future Analysis for Other Biochips by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 26. World Historic Review for Other Biochips by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 27. World 14-Year Perspective for Other Biochips by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)

Analysis by Application

Table 28. World Recent Past, Current & Future Analysis for Biochips by Application - Research, Diagnostics, and Other Application Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 29. World Historic Review for Biochips by Application - Research, Diagnostics, and Other Application Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 30. World 14-Year Perspective for Biochips by Application - Percentage Breakdown of Dollar Sales for Research, Diagnostics, and Other Application Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)

10. REGIONAL MARKET PERSPECTIVE

10.1 The United States
A. Market Analysis
United States: The Global Leader for Biochips
Rising Demand in Biotechnology and Life Science Research Applications
Lab-on-a-Chip: The Leading Segment
Rapid Growth for Protein Biochips
DNA Biochip Market
Growth Drivers
Demand for Personalized Medicine Drives Market for Biochips
Aging Population: A Strong Demographic Driver

Table 31. US Elderly Population by Age Group (2000-2050) (includes corresponding Graph/Chart)

Table 32. The US Population Breakdown by Age Group (2015) (includes corresponding Graph/Chart)

Growing Incidence of Cancer & Lifestyle Disorders
Opportunity Indicators: Statistics Depicting Increasing Incidence of Cancer and Lifestyle Disorders

Table 33. The US Cancer Incidence by Gender (2017): No. of Reported New Cases for Men and Women (includes corresponding Graph/Chart)

Table 34. Cancer Incidence in the US by Affected Site (2017): Number of New Cancer Cases (includes corresponding Graph/Chart)

Table 35. Prevalence of Diabetes Mellitus in the US (2013 & 2035): Number of People with DM (in Thousands) in the 20-79 Age Group for the US

Competition
B. Market Analytics

Table 36. The US Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 37. The US Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 38. The US 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)

10.2 Canada
A. Market Analysis
Current and Future Analysis
Rising Incidence of Chronic Diseases Spurs Biochips Demand
Opportunity Indicators for Biochips Market:

Table 39. New Cancer Cases in Canada by Gender and Affected Site (2017) (includes corresponding Graph/Chart)

Table 40. New Cancer Cases in Canada by Province (2017) (includes corresponding Graph/Chart)

Table 41. Prevalence of Diabetes Mellitus in Canada (2013 & 2035): Number of People with DM (in Thousands) in the 20-79 Age Group

B. Market Analytics

Table 42. Canadian Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 43. Canadian Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 44. Canadian 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)

10.3 Japan
A. Market Analysis
Current and Future Analysis
Elderly Population Boosts the Biochip Market

Table 45. Japanese Elderly (65+ Years) Population: 2000-2050 (in Thousands) (includes corresponding Graph/Chart)

B. Market Analytics

Table 46. Japanese Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 47. Japanese Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 48. Japanese 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)

10.4 Europe
A. Market Analysis
Current and Future Analysis
Leader in the DNA Biochip Segment
Lab-on-chip Market in Europe
European Advancements Shape Diagnostic Procedures
Ageing Population Boosts Demand

Table 49. European Country-wise Statistics of 60+ Population as % of Total Population: 2015 (includes corresponding Graph/Chart)

Opportunity Indicator for the Biochips Market: European Personalized Medicine Market Exhibits Robust Growth
Increasing Incidence of Cancer Drives Biochips Demand

Table 50. Cancer Incidence in Europe by Site: 2012 (in Thousands) (includes corresponding Graph/Chart)

B. Market Analytics

Table 51. European Recent Past, Current & Future Analysis for Biochips by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 52. European Historic Review for Biochips by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 53. European 14-Year Perspective for Biochips by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)

Table 54. European Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 55. European Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 56. European 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)

  10.4.1 France
Market Analysis

Table 57. French Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 58. French Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 59. French 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)

  10.4.2 Germany
A. Market Analysis
Current and Future Analysis
Berlin, Brandenburg and Biochips
B. Market Analytics

Table 60. German Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 61. German Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 62. German 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)

  10.4.3 Italy
Market Analysis

Table 63. Italian Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 64. Italian Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 65. Italian 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)

  10.4.4 The United Kingdom
Market Analysis

Table 66. UK Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 67. UK Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 68. UK 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)

  10.4.5 Spain
Market Analysis

Table 69. Spanish Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 70. Spanish Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 71. Spanish 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)

  10.4.6 Russia
Market Analysis

Table 72. Russian Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 73. Russian Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 74. Russian 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)

  10.4.7 Rest of Europe
Market Analysis

Table 75. Rest of Europe Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 76. Rest of Europe Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 77. Rest of Europe 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)

10.5 Asia-Pacific
A. Market Analysis
Current and Future Analysis
Increased Healthcare Spending Boosts the Biochips Market
India & China Offer Significant Growth Opportunities

Table 78. Ten Largest Populated Countries Worldwide (2015): Percentage Population by Age Group for 0-14 Years, 15-44 Years, 45-64 Years, and 65+ Years for China, India, USA, Indonesia, Brazil, Pakistan, Nigeria, Bangladesh, Russia and Japan (includes corresponding Graph/Chart)

Table 79. Over 65 Years Individuals as % of Total Population in Select Asian Countries (2015) (includes corresponding Graph/Chart)

Rising Diabetes Incidence in Asia-Pacific Offers Significant Growth Opportunities

Table 80. Prevalence of Diabetes Mellitus in South East Asia (2013 & 2035): Number of People with DM (in Thousands) in the 20-79 Age Group for Bangladesh, Bhutan, India, Maldives, Mauritius, Nepal, and Sri Lanka (includes corresponding Graph/Chart)

Table 81. Prevalence of Diabetes Mellitus in Western Asia-Pacific Regions (2013 & 2035): Number of People with DM (in thousands) in the 20-79 Age Group for 27 Countries in the Region (includes corresponding Graph/Chart)

B. Market Analytics

Table 82. Asia-Pacific Recent Past, Current & Future Analysis for Biochips by Geographic Region - China, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 83. Asia-Pacific Historic Review for Biochips by Geographic Region - China, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 84. Asia-Pacific 14-Year Perspective for Biochips by Geographic Region - Percentage Breakdown of Dollar Sales for China, and Rest of Asia-Pacific Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)

Table 85. Asia-Pacific Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 86. Asia-Pacific Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 87. Asia-Pacific 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)

  10.5.1 China
A. Market Analysis
Current and Future Analysis
Basic Environment and Commercial Development
Biochip Research Institutes
Favorable Personalized Medicine Market Boosts Demand for Biochips
B. Market Analytics

Table 88. Chinese Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 89. Chinese Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 90. Chinese 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)

  10.5.2 Rest of Asia-Pacific
A. Market Analysis
Current and Future Analysis
India: Growing Investments in Pharmacogenomics Research Drives Biochips Market
B. Market Analytics

Table 91. Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 92. Rest of Asia-Pacific Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 93. Rest of Asia-Pacific 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)

10.6 Latin America
Market Analysis

Table 94. Latin American Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 95. Latin American Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 96. Latin American 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)

10.7 Rest of World
Market Analysis

Table 97. Rest of World Recent Past, Current & Future Analysis for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 98. Rest of World Historic Review for Biochips by Product Segment - DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 99. Rest of World 14-Year Perspective for Biochips by Product Segment - Percentage Breakdown of Dollar Sales for DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Other Markets for Years 2011, 2018 & 2024 (includes corresponding Graph/Chart)

11. COMPANY PROFILES

Total Companies Profiled: 73 (including Divisions/Subsidiaries - 79)
The United States (40)
Canada (2)
Japan (6)
Europe (21)
  France (2)
  Germany (7)
  The United Kingdom (3)
  Spain (1)
  Rest of Europe (8)
Asia-Pacific (Excluding Japan) (10)